BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25461250)

  • 1. Melatonin overcomes resistance to clofarabine in two leukemic cell lines by increased expression of deoxycytidine kinase.
    Yamanishi M; Narazaki H; Asano T
    Exp Hematol; 2015 Mar; 43(3):207-14. PubMed ID: 25461250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug resistance to nelarabine in leukemia cell lines might be caused by reduced expression of deoxycytidine kinase through epigenetic mechanisms.
    Yoshida K; Fujita A; Narazaki H; Asano T; Itoh Y
    Cancer Chemother Pharmacol; 2022 Jan; 89(1):83-91. PubMed ID: 34825941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance.
    Månsson E; Flordal E; Liliemark J; Spasokoukotskaja T; Elford H; Lagercrantz S; Eriksson S; Albertioni F
    Biochem Pharmacol; 2003 Jan; 65(2):237-47. PubMed ID: 12504799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deoxycytidine kinase modulates the impact of the ABC transporter ABCG2 on clofarabine cytotoxicity.
    Nagai S; Takenaka K; Nachagari D; Rose C; Domoney K; Sun D; Sparreboom A; Schuetz JD
    Cancer Res; 2011 Mar; 71(5):1781-91. PubMed ID: 21245102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clofarabine exerts antileukemic activity against cytarabine-resistant B-cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression.
    Huang M; Inukai T; Miyake K; Tanaka Y; Kagami K; Abe M; Goto H; Minegishi M; Iwamoto S; Sugihara E; Watanabe A; Somazu S; Shinohara T; Oshiro H; Akahane K; Goi K; Sugita K
    Cancer Med; 2018 Apr; 7(4):1297-1316. PubMed ID: 29473342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical pharmacology and resistance to 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, a novel analogue of cladribine in human leukemic cells.
    Lotfi K; Månsson E; Spasokoukotskaja T; Pettersson B; Liliemark J; Peterson C; Eriksson S; Albertioni F
    Clin Cancer Res; 1999 Sep; 5(9):2438-44. PubMed ID: 10499616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of a murine P388 leukemia line resistant to clofarabine.
    Waud WR; Gilbert KS; Parker WB; Secrist JA
    Nucleosides Nucleotides Nucleic Acids; 2011 Nov; 30(11):826-38. PubMed ID: 22060549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stratification of nucleoside analog chemotherapy using 1-(2'-deoxy-2'-18F-fluoro-β-D-arabinofuranosyl)cytosine and 1-(2'-deoxy-2'-18F-fluoro-β-L-arabinofuranosyl)-5-methylcytosine PET.
    Lee JT; Campbell DO; Satyamurthy N; Czernin J; Radu CG
    J Nucl Med; 2012 Feb; 53(2):275-80. PubMed ID: 22302964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytarabine-resistant leukemia cells are moderately sensitive to clofarabine in vitro.
    Yamauchi T; Uzui K; Nishi R; Shigemi H; Ueda T
    Anticancer Res; 2014 Apr; 34(4):1657-62. PubMed ID: 24692694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of DNA methylation of the 5' region of the deoxycytidine kinase gene in CCRF-CEM-sensitive and cladribine (CdA)- and 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine (CAFdA)-resistant cells.
    Leegwater PA; De Abreu RA; Albertioni F
    Cancer Lett; 1998 Aug; 130(1-2):169-73. PubMed ID: 9751270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clofarabine activity in childhood and adult acute leukemia: individual tumor response study.
    Styczynski J; Gil L; Derwich K; Wachowiak J; Balwierz W; Badowska W; Krawczuk-Rybak M; Matysiak M; Wieczorek M; Balcerska A; Sonta-Jakimczyk D; Stefaniak J; Kowalczyk J; Urasinski T; Sobol G; Komarnicki M; Wysocki M
    Anticancer Res; 2009 May; 29(5):1643-50. PubMed ID: 19443380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structure of human deoxycytidine kinase in complex with clofarabine reveals key interactions for prodrug activation.
    Zhang Y; Secrist JA; Ealick SE
    Acta Crystallogr D Biol Crystallogr; 2006 Feb; 62(Pt 2):133-9. PubMed ID: 16421443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
    Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
    J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clofarabine and nelarabine: two new purine nucleoside analogs.
    Gandhi V; Plunkett W
    Curr Opin Oncol; 2006 Nov; 18(6):584-90. PubMed ID: 16988579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Deazauridine enhances the antileukemic action of 5-aza-2'-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase.
    Raynal NJ; Momparler LF; Rivard GE; Momparler RL
    Leuk Res; 2011 Jan; 35(1):110-8. PubMed ID: 20510451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and biochemical mechanisms of fludarabine and cladribine resistance in a human promyelocytic cell line.
    Månsson E; Spasokoukotskaja T; Sällström J; Eriksson S; Albertioni F
    Cancer Res; 1999 Dec; 59(23):5956-63. PubMed ID: 10606241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low level of mitochondrial deoxyguanosine kinase is the dominant factor in acquired resistance to 9-beta-D-arabinofuranosylguanine cytotoxicity.
    Lotfi K; Månsson E; Peterson C; Eriksson S; Albertioni F
    Biochem Biophys Res Commun; 2002 May; 293(5):1489-96. PubMed ID: 12054684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel leukemic cell lines resistant to clofarabine by mechanisms of decreased active metabolite and increased antiapoptosis.
    Shigemi H; Yamauchi T; Tanaka Y; Ueda T
    Cancer Sci; 2013 Jun; 104(6):732-9. PubMed ID: 23421409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of resistance to cytosine arabinoside (Ara-C) in NALM-6 human B leukemia cells.
    Kanno S; Hiura T; Ohtake T; Koiwai K; Suzuki H; Ujibe M; Ishikawa M
    Clin Chim Acta; 2007 Feb; 377(1-2):144-9. PubMed ID: 17097625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo induced mutations in the deoxycytidine kinase (dck) gene in rat leukemic clonal cell lines confer resistance to cytarabine (AraC) and 5-aza-2'-deoxycytidine (DAC).
    Stegmann AP; Honders MW; Willemze R; Landegent JE
    Leukemia; 1995 Jun; 9(6):1032-8. PubMed ID: 7541096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.